Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar WakiDay (< 20) Submitted: 1/8/2010 12:27:21 PM : Outperform Start Price: $10.86 INCY Score: +90.62

GREAT drug development stock.

Report this Post Reply

Featured Broker Partners


Advertisement